Morgan Stanley (MS) Position Reduced by OppenheimerFunds Inc.

OppenheimerFunds Inc. lessened its stake in Morgan Stanley (NYSE:MS) by 17.1% in the 4th quarter, HoldingsChannel reports. The fund owned 2,031,864 shares of the financial services provider’s stock after selling 419,583 shares during the quarter. OppenheimerFunds Inc.’s holdings in Morgan Stanley were worth $106,612,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of MS. DSAM Partners London Ltd acquired a new stake in Morgan Stanley during the 3rd quarter worth $5,273,000. Stifel Financial Corp boosted its stake in Morgan Stanley by 301.3% during the 3rd quarter. Stifel Financial Corp now owns 577,918 shares of the financial services provider’s stock worth $27,842,000 after purchasing an additional 433,920 shares during the last quarter. CAPROCK Group Inc. acquired a new stake in Morgan Stanley during the 3rd quarter worth $220,000. Taylor Wealth Management Partners boosted its stake in Morgan Stanley by 1,353.0% during the 4th quarter. Taylor Wealth Management Partners now owns 7,265 shares of the financial services provider’s stock worth $381,000 after purchasing an additional 6,765 shares during the last quarter. Finally, Donaldson Capital Management LLC acquired a new stake in Morgan Stanley during the 3rd quarter worth $1,343,000. 86.32% of the stock is owned by institutional investors.

In other Morgan Stanley news, Chairman James P. Gorman sold 100,000 shares of the company’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $55.34, for a total value of $5,534,000.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Jonathan Pruzan sold 52,204 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.35, for a total transaction of $2,889,491.40. The disclosure for this sale can be found here. Insiders sold 264,254 shares of company stock worth $14,335,019 in the last ninety days. 0.35% of the stock is currently owned by corporate insiders.

Morgan Stanley (NYSE MS) opened at $56.07 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 2.68. The firm has a market cap of $98,089.68, a PE ratio of 18.15, a PEG ratio of 0.95 and a beta of 1.54. Morgan Stanley has a 1 year low of $40.06 and a 1 year high of $58.05.

Morgan Stanley (NYSE:MS) last announced its quarterly earnings results on Thursday, January 18th. The financial services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.07. The firm had revenue of $9.50 billion for the quarter, compared to analysts’ expectations of $9.25 billion. Morgan Stanley had a net margin of 14.10% and a return on equity of 10.03%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.81 EPS. analysts expect that Morgan Stanley will post 4.51 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st were given a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, January 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.78%. Morgan Stanley’s payout ratio is currently 32.36%.

Several brokerages have issued reports on MS. Atlantic Securities raised shares of Morgan Stanley from a “neutral” rating to an “overweight” rating and set a $61.00 target price on the stock in a research note on Wednesday, January 10th. UBS Group raised shares of Morgan Stanley to an “overweight” rating in a research note on Wednesday, January 10th. Keefe, Bruyette & Woods raised shares of Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 target price on the stock in a research note on Tuesday, December 12th. Zacks Investment Research raised shares of Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 target price on the stock in a research note on Monday, December 11th. Finally, Societe Generale set a $61.00 target price on shares of Morgan Stanley and gave the stock a “neutral” rating in a research note on Monday, January 22nd. One analyst has rated the stock with a sell rating, seven have issued a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $54.07.

WARNING: This news story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://ledgergazette.com/2018/02/24/morgan-stanley-ms-position-reduced-by-oppenheimerfunds-inc.html.

Morgan Stanley Company Profile

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply